Article
CD5L is a Potential Hepatocellular Carcinoma Biomarker for Clinical prognostic and immunotherapy
2023-02-16
Abstract excerpt
CD5L acts as an important regulator of inflammation by suppressing the immune response and blocking the secretion of pro-inflammatory cytokines. However, systematic evaluations of CD5L-related genes in human cancers are lacking, particularly in their predictive role in hepatocellular carcinoma progression. Here, we obtained data from the Tumor Genome Atlas (TCGA), an open database website, to evaluate CD5L mRNA ex...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 45bb8103-97cd-5183-a4d6-aae63540b05d
- DOI
- 10.21203/rs.3.rs-2586807/v1
